The Russian Direct Investment Fund (RDIF) has announced the registration of the Russian Sputnik V vaccine against coronavirus by Palestine’s Health Ministry, the Fund said in a statement on Monday.
“The vaccine was registered under the emergency use authorization procedure without additional clinical trials on the territory of the state,” the statement said.
Supplies of the vaccine to Palestine are planned for Q1 2021, the first batch is expected within a month, according to RDIF.
The supplies of the vaccine will be facilitated by RDIF’s international partners in India, China, South Korea and other countries.
Sputnik V was registered under the same procedure earlier in Algeria, Argentina, Bolivia and Serbia.